GHK-Cu (Copper Peptide)
A copper-binding tripeptide used as an ingredient in topical cosmetic products.
What it is
GHK-Cu is a naturally occurring copper-binding tripeptide found in human plasma, whose levels decline with age. In commerce it is a cosmetic ingredient — one of the few peptides in this library with a legitimate over-the-counter home.
Topical GHK-Cu has small human studies on skin appearance — fine lines, elasticity, wound-adjacent endpoints — the kind of evidence cosmetic regulation contemplates, well short of drug-level proof. Injectable GHK-Cu sold online is a different product in a different (unregulated) channel and shouldn't borrow the topical evidence.
What researchers have actually studied it for
Skin appearance and wound-adjacent endpoints in small topical studies; broader regenerative claims rest on lab work.
How it works
The tripeptide glycyl-histidyl-lysine binds copper and ferries it into tissue, where lab studies show it stimulating collagen and glycosaminoglycan synthesis, modulating metalloproteinases (the enzymes that remodel skin), and nudging gene expression toward repair programs. Cosmetic formulations bank on those dermal effects.
The molecule itself
Glycyl-L-histidyl-L-lysine — a tripeptide with a high-affinity copper(II) binding site formed by the histidine's imidazole ring. The copper complex is the famous blue. Naturally present in plasma at levels that decline several-fold from youth to older age, a decline central to its aging narrative.
Where it came from
Discovered in 1973 by biochemist Loren Pickart, who noticed old liver tissue behaved younger in the presence of a plasma factor — GHK. Five decades of his and others' lab work built the repair narrative; the cosmetics industry adopted it broadly in the 1990s, making the blue copper-peptide serum a category staple.
The timeline
1973
Pickart identifies the plasma factor making aged liver tissue behave younger.
1980s–90s
Copper-complex biology characterized; wound and remodeling studies accumulate.
1990s
Cosmetics industry adoption; the copper-peptide serum category forms.
2000s–10s
Small controlled topical studies report modest wrinkle and elasticity improvements.
2010s+
Gene-expression profiling papers fuel 'skin reprogramming' marketing; injectable gray market emerges.
What the research record actually contains
- Decades of cell and animal studies on collagen synthesis and tissue remodeling.
- Small controlled human studies of topical formulations: modest improvements in fine lines, elasticity and skin density.
- Hair-follicle lab work underpinning haircare use; controlled human regrowth trials absent.
- No human evidence for injectable use — a different route with no oversight.
What could change this assessment
The serious thread is wound-care materials science — GHK-loaded dressings and scaffolds in academic development. Cosmetically, expect ingredient-cycle marketing (new formats, same small evidence base). The injectable trend has no research future, only regulatory risk.
What's known about risks
Topically: long cosmetic history, low irritation, well tolerated. Injectable gray-market use has no human safety data — and copper delivery by injection is not a casually self-administered idea.
Where it stands legally
Lawful as a cosmetic ingredient in topical products. Injectable versions have no approved or compounded pathway — research-chemical territory.
Worth asking a licensed provider
- 1.For my skin goals, how does copper peptide compare with proven options like retinoids?
- 2.Is there any reason to consider more than topical use? (The honest answer should be no.)
- 3.What realistic timeline and effect size should I expect from cosmetic-tier evidence?
Common claims, corrected
“It resets your skin's gene expression.”
Reality: Cell-culture studies show broad expression shifts — a hypothesis-generating lab finding that marketing upgraded to a clinical outcome nobody has measured on faces.
“Stronger (bluer) serums work better.”
Reality: The blue confirms copper-complex presence, not effective concentration or delivery — and no dose-response data exists for retail products anyway.
GHK-Cu (Copper Peptide) FAQ
Does copper peptide actually work for skin?
Small controlled studies of topical GHK-Cu report improvements in measures like fine lines and elasticity. The effect sizes are modest and the studies small — real but cosmetic-tier evidence.
Is GHK-Cu safe?
As a topical cosmetic ingredient it has a long history of use. Injectable forms sold online have no established safety profile and no regulatory oversight.
Can GHK-Cu regrow hair?
Copper peptides appear in hair-care formulations and lab studies show follicle-relevant activity, but controlled human trials demonstrating regrowth are lacking. Treat regrowth claims as unproven.
Does GHK-Cu help wound healing in humans?
Its serious research lives in wound-care materials — dressings and scaffolds in development, mostly preclinical. That's genuinely promising and entirely unrelated to cosmetic serums or gray-market injections.
Can I use copper peptides with retinoids?
Formulation compatibility varies (strong acids are the classic conflict); many routines separate them by time of day. A dermatologist beats a serum brand's FAQ for your specific stack.